Lisata and Kuva Labs partner for MR imaging agents to detect cancer
The partnership is set to leverage Lisata's certepetide for usage with Kuva’s NanoMark platform technology.
The partnership is set to leverage Lisata's certepetide for usage with Kuva’s NanoMark platform technology.